Maternus-Kliniken Aktiengesellschaft (MAK) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.036x

Based on the latest financial reports, Maternus-Kliniken Aktiengesellschaft (MAK) has a cash flow conversion efficiency ratio of 0.036x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.76 Million ≈ $-2.06 Million USD) by net assets (€-48.52 Million ≈ $-56.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Maternus-Kliniken Aktiengesellschaft (MAK) total market value for the company's overall valuation and market capitalisation.

Maternus-Kliniken Aktiengesellschaft - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Maternus-Kliniken Aktiengesellschaft's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Maternus-Kliniken Aktiengesellschaft Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Maternus-Kliniken Aktiengesellschaft ranked by their cash flow conversion efficiency. Explore MAK operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Ecocab Co. Ltd KQ:128540	0.095x
Cavendish Hydrogen ASA OL:CAVEN	-0.092x
Rectitude Holdings Ltd Ordinary Shares NASDAQ:RECT	-0.063x
Seven Principles AG XETRA:T3T1	-0.092x
Hanwha Investment&Securities Co Ltd Pref KO:003535	-0.108x
Southern Fertilizer JSC VN:SFG	0.325x
88 Energy Ltd AU:88E	-0.020x
Ordinary Fully Paid Deferred Settlement AU:88EDA	N/A

Annual Cash Flow Conversion Efficiency for Maternus-Kliniken Aktiengesellschaft (2013–2025)

The table below shows the annual cash flow conversion efficiency of Maternus-Kliniken Aktiengesellschaft from 2013 to 2025. View Maternus-Kliniken Aktiengesellschaft stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€-80.59 Million ≈ $-94.22 Million	€14.03 Million ≈ $16.40 Million	-0.174x	+22.81%
2024-12-31	€-66.84 Million ≈ $-78.14 Million	€15.07 Million ≈ $17.62 Million	-0.226x	-380.34%
2023-12-31	€-53.76 Million ≈ $-62.85 Million	€2.52 Million ≈ $2.95 Million	-0.047x	+57.38%
2022-12-31	€-39.30 Million ≈ $-45.94 Million	€4.33 Million ≈ $5.06 Million	-0.110x	+82.21%
2021-12-31	€-27.85 Million ≈ $-32.56 Million	€17.24 Million ≈ $20.16 Million	-0.619x	-29.31%
2020-12-31	€-25.41 Million ≈ $-29.70 Million	€12.17 Million ≈ $14.22 Million	-0.479x	+52.69%
2019-12-31	€-15.84 Million ≈ $-18.52 Million	€16.03 Million ≈ $18.74 Million	-1.012x	+11.92%
2018-12-31	€-5.42 Million ≈ $-6.34 Million	€6.23 Million ≈ $7.29 Million	-1.149x	+53.95%
2017-12-31	€-3.82 Million ≈ $-4.46 Million	€9.53 Million ≈ $11.14 Million	-2.495x	+25.86%
2016-12-31	€-2.35 Million ≈ $-2.75 Million	€7.90 Million ≈ $9.24 Million	-3.365x	-130.34%
2015-12-31	€-262.00K ≈ $-306.31K	€-2.91 Million ≈ $-3.40 Million	11.092x	+368.97%
2014-12-31	€-2.74 Million ≈ $-3.20 Million	€11.30 Million ≈ $13.21 Million	-4.124x	-312.37%
2013-12-31	€3.83 Million ≈ $4.47 Million	€7.43 Million ≈ $8.69 Million	1.942x	--

About Maternus-Kliniken Aktiengesellschaft

F:MAK Germany Medical Care Facilities

Market Cap

$20.47 Million

€17.51 Million EUR

Market Cap Rank

#25401 Global

#2173 in Germany

Share Price

€0.84

Change (1 day)

+0.00%

52-Week Range

€0.83 - €4.26

All Time High

€5.55